HOME >> MEDICINE >> NEWS
Studies suggest investigational agent reduces disease activity in MS

BOSTON A new drug under investigation shows a reduction in disease activity in multiple sclerosis (MS), according to two studies that will be presented at the American Academy of Neurology's 59th Annual Meeting in Boston, April 28 May 5, 2007. The drug reduced disease activity as indicated by MRI scans.

Both of the studies involved people with the relapsing-remitting form of MS, where symptoms flare up and then subside. By 24 weeks, treatment with the drug rituximab reduced the number of areas of brain damage, or lesions, in people with MS and the number of relapses, or times when symptoms flare up, when compared with placebo.

Rituximab is a therapeutic antibody that selectively targets and depletes a subset of immune cells called B-cells by targeting a specific protein on their surface.

"This is the first drug to target B-cells and may represent a potential new treatment strategy for relapsing-remitting MS," said study author Stephen Hauser, MD, of the University of California, San Francisco, and a member of the American Academy of Neurology. "While these are early stage clinical trials, these results are exciting, because the current drugs available for MS are only partially effective in reducing disease activity and preventing exacerbations. New and more effective treatments for MS are sorely needed, especially for people who do not adequately respond to currently available medications. These data are also important because they demonstrate that B-cells, which are the precursors of antibody-producing cells, play an essential role in mediating relapses of MS."

In the first study, a randomized, placebo-controlled trial, 69 people were given two infusions of rituximab two weeks apart and 35 were given a placebo. The participants were followed for six months. Those given rituximab had approximately 90 percent fewer brain lesions than those given placebo. During the six-month period, 58 percent fewer of those taking the d
'"/>

Contact: Angela Babb
ababb@aan.com
651-695-2789
American Academy of Neurology
1-May-2007


Page: 1 2 3

Related medicine news :

1. Studies show antidepressants not linked to birth defects
2. Studies show role of age, gender, race and weight on cancer risk and treatment
3. Studies highlight advances in diagnosis, medical therapy
4. Studies highlight real world use, safety of drug-eluting stents
5. Studies led by Rhode Island Hospital confirm safety and efficacy
6. Studies identify food sources of disease and drug resistance
7. Studies provide new evidence on risks associated with Cox-2 inhibitors and NSAIDs
8. Studies highlight need to monitor heart function in breast cancer patients
9. Studies examine physician disclosure of medical errors
10. Studies indicate medication can be an effective therapy for smoking cessation
11. Studies evaluating health effects of dental amalgam fillings in children confirm safety

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/21/2020)... (PRWEB) , ... February 21, 2020 , ... ... that it is now offering a 10 percent grand opening discount 0n its ... percent off all purchases," said Osmay Gonzalez, spokesperson for Baby Blendy LLC, a ...
(Date:2/21/2020)... (PRWEB) , ... February 21, 2020 , ... ... grafting or autologous fat transfer continues to garner traction as a viable replacement ... released by Fact.MR, North America is predicted to remain the market leader for ...
(Date:2/21/2020)... ... 21, 2020 , ... The American Society for Clinical Pathology ... Boston, MA, in October 2021. The prestigious, invitation-only event—organized by the Union for ... of health, city and industry leaders, senior executives and other influential players ...
(Date:2/20/2020)... VEGAS (PRWEB) , ... February 20, 2020 , ... R3 ... in Las Vegas Nevada. Providers will learn how to perform injections for all large ... is not easy to learn from online videos. The best opportunity is to perform ...
(Date:2/20/2020)... ... February 20, 2020 , ... Millennial women are flocking ... Laser Center in Milford, Penn requesting treatments to achieve “ Rich Girl Face .” ... look like it is slowing down into 2020. It’s a look inspired by the ...
Breaking Medicine News(10 mins):
(Date:2/28/2020)... ... February 27, 2020 , ... ... Behavior Analysis (ABA) solutions with the mission to bring quality ABA intervention to ... services, and an educational suite comprised of curriculum and teaching materials to enable ...
(Date:2/26/2020)... ... 26, 2020 , ... SGF is the largest fertility center in Virginia, and ... two decades. With seven locations in Northern Virginia, the addition of our newest physician, ... 1 reproductive urologist. SGF Fairfax’s lab director recently shared just a few of the ...
(Date:2/23/2020)... ... ... Cred International Co., Ltd. has proudly announced that it is introducing the ... new spa is located at a luxurious old Castle Hotel & Spa and will ... Cred International began its services on February 1st, 2020, and it is already getting ...
Breaking Medicine Technology:
Cached News: